The National Cancer Institute, Pennsylvania Bio, and the Innovation Partnership
Invite You to Learn About New Funding Opportunities for Small Businesses

September 29, 2008
Malvern, PA

On September 29^th, Greg Evans, Program Director and Team Leader, SBIR Development Center, National Cancer Institute, discussed the diverse SBIR and STTR funding opportunities and offer tips for applying.  SBIR has recently released exciting new funding opportunities.

 Click here to download the presentation from the event.

The SBIR Program announced 18 new contract funding opportunities in a range of novel technology areas to help successfully finance and lead innovations to commercialization. The NCI SBIR Program solicits proposals for SBIR contracts once annually. As compared to grant funding opportunities, SBIR contract topics are focused in scope and require the completion of specific activities and deliverables. In order to catalyze targeted technology development in key need areas that will result in a commercial product, the NCI SBIR Program is moving more of its resources towards contracts. The SBIR and STTR Programs offer funding in nanotechnology, anti-cancer agents, biomarkers, proteomics, pharmacodynamics, and many more areas of interest to the NCI.

• Contract Topics
• SBIR Phase II Bridge Award

The new Phase II Bridge award is specifically designed to augment previously funded NIH-wide SBIR Phase II projects that require additional funding in order to achieve key technical and regulatory milestones along the path toward commercialization. Phase II Bridge Award applicants may request budgets up to $1 million in total costs per year and project periods up to three years (a total of $3 million over three years) from the NCI. 

For more information on the Innovation Partnership, PA's Premiere SBIR/STTR Federal R&D Funding Assistance Program visit www.innovationpartnership.net.

About the SBIR & STTR Programs

The goal of the National Cancer Institute is to eliminate the suffering and death due to cancer. The SBIR & STTR Programs are NCI's engines of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. For more information, please email This e-mail address is being protected from spam bots, you need JavaScript enabled to view it   or visit sbir.cancer.gov.

To participate in the SBIR Program, a company must be:

• An organized for-profit U.S. business
• 500 employees or fewer, including affiliates
• Principal Investigator's primary employment must be with the small business concern at the time of award and for the duration of the project period
• Small business concern must be:
  • At least 51% U.S.-owned by individuals and independently operated
    or
  • At least 51% owned and controlled by a for-profit business concern that is at least 51% owned and controlled by one or more individuals    

Sign up to receive the latest updates about SBIR & STTR funding opportunities